Skip to main content


In 2021, the global brain modalities and software market was valued at $13,343.3 million, which is set to reach $23,195.6 million by 2030, at a CAGR of 5.2% during 2021–2030. The growing patient emphasis on early and effective disease diagnosis, advancing demand for non-invasive and safer medical imaging, and surging prevalence of neurological disorders are the key factors that drive the market.


Comments